Results of colestipol therapy in type II hyperlipoproteinemia
- 1 July 1976
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 24 (1-2) , 129-140
- https://doi.org/10.1016/0021-9150(76)90070-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Colestipol and clofibrate in hypercholesterolemiaClinical Pharmacology & Therapeutics, 1974
- Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTSJournal of Clinical Investigation, 1974
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- Inducible Metabolic Abnormalities During Development of ObesityAnnual Review of Medicine, 1971
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970
- Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.Published by Elsevier ,1968
- EditorialCirculation, 1965
- The interrelationship of serum cholesterol, hypertension, body weight, and risk of coronary disease: Results of the first ten years' follow-up in the Los Angeles Heart StudyJournal of Chronic Diseases, 1964
- The Use of Orally-fed Liquid Formulas in Metabolic StudiesThe American Journal of Clinical Nutrition, 1954